Computerised record linkage: Compared with traditional patient follow-up methods in clinical trials and illustrated in a prospective epidemiological study

Journal of Clinical Epidemiology

Volumn 48, Issue 12, 1995, Pages 1441-1452

[No Author Info available]

Author keywords

Adverse event reporting; Clinical trial; Computerised record linkage; Coronary heart disease

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PRAVASTATIN;

ADULT; ARTICLE; AUTOMATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FOLLOW UP; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRIMARY PREVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

ADVERSE DRUG REACTION REPORTING SYSTEMS; CORONARY DISEASE; DOUBLE-BLIND METHOD; ENZYME INHIBITORS; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MEDICAL RECORD LINKAGE; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; MIDDLE AGED; MORTALITY; MYOCARDIAL INFARCTION; NEOPLASMS; PRAVASTATIN; PROSPECTIVE STUDIES; RISK FACTORS; SCOTLAND;

EID: 9044240042     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/0895-4356(95)00530-7     Document Type: Article

References (39)

1. Medical record linkage in Scotland
2. Helsinki heart study: Primary prevention trial with Gemfibrozil in middle-aged men with dyslipidemia: Safety of treatment, changes in risk factors, and incidence of coronary heart disease
3. The Scottish Record linkage System
4. HMG CoA reductase inhibitors: clinical pharmacology
5. CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: tissue—selective inhibition of sterol synthesis and hypolipidemic effect on various animal species
6. Pravastatin sodium: A novel cholesterol-lowering agent that inhibits HMG CoA reductase
7. Influence of pravastatin a specific inhibitor of HMG CoA reductase on hepatic metabolism of cholesterol
8. Disposition of pravastatin sodium, a tissue-selective HMG-CoA reductase inhibitor, in healthy subjects
9. Pravastatin therapy in primary moderate hypercholesterolaemia: Changes in metabolism of apolipoprotein B-containing lipoproteins
10. Tissue-selective acute effects of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase on cholesterol biosynthesis in the lens
11. A coronary primary prevention study of Scottish men aged 45–64 years Trial design
12. A theory for record linkage
13. The use of names for linking personal records
14. Concomitants of excess coronary deaths—major risk factor and lifestyle findings from 10359 men and women in the Scottish heart Health Study
15. The relative importance of selected risk factors for various manifestations of cardiovascular disease among men and women from 35–64 years old: 30 years of follow-up in the Framingham Study
16. Concentrations of high density lipoprotein cholesterol, triglycerides, and total cholesterol in ischaemic heart disease
17. Serum cholesterol, blood pressure, and mortality: Implications from a cohort of 361,662 men
18. An analysis of randomised trials evaluating the effect of cholesterol reduction on total mortality and coronary heart disease incidence
19. Strategies for reducing coronary heart disease and desirable limits for blood lipid concentrations: Guidelines of the British Hyperlipidaemia Association
20. Are low cholesterol values associated with excess mortality?
21. Serum cholesterol levels and cancer mortality in 361,662 men screened for the Multiple Risk Factor Intervention Trial
22. The serum cholesterol-cancer relationship: An analysis of time trends in the Framingham Study
23. Plasma cholesterol, coronary heart disease, and cancer in the Renfrew and Paisley survey
24. Report of the conference on low blood cholesterol: Mortality associations
25. Health policy on blood cholesterol: Time to change directions
26. Lowering cholesterol concentrations and mortality: A quantitative review of primary prevention trials
27. Assessing possible hazards of reducing serum cholesterol
28. Coronary heart disease mortality and alcohol consumption in Framingham
29. Death certification
30. Mortality in patients of the Glasgow blood pressure clinic
31. Cohort follow-up using computer linkage with routinely collected data
32. Comparison of individual follow-up and computerised record linkage using the Canadian mortality database
33. Reliability of computerised versus manual death searches in a study of the health of Eldorado uranium miners
34. A mortality study of 11,500 nickel workers
35. Cancer mortality associated with the high-temperature oxidation of nickel subsulfide